Loading clinical trials...
Loading clinical trials...
The purpose of the study is to follow tumoral proteins metabolism by in vivo no radioactive isotopic tagging (carbon 13 and nitrogen 15).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Grenoble
Collaborators
NCT06829173 · High-Grade Glioma
NCT06624371 · High-grade Glioma, Medulloblastoma, and more
NCT06660056 · High-grade Gliomas
NCT06763965 · Recurrent High-grade Glioma
NCT07532031 · High-Grade Glioma, Glioblastoma, and more
CLINATEC
Grenoble
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions